GSK-1995057
| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Antibody | INHIBITOR | Tumor necrosis factor receptor R1 inhibitor | no | 1 | 0 |
| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Antibody | INHIBITOR | Tumor necrosis factor receptor R1 inhibitor | no | 1 | 0 |